142 related articles for article (PubMed ID: 32152165)
21. Concerns and perceptions about necessity in relation to insulin therapy in an ethnically diverse UK population with Type 2 diabetes: a qualitative study focusing mainly on people of South Asian origin.
Patel N; Stone MA; McDonough C; Davies MJ; Khunti K; Eborall H
Diabet Med; 2015 May; 32(5):635-44. PubMed ID: 25439281
[TBL] [Abstract][Full Text] [Related]
22. Converting to insulin in primary care: an exploration of the needs of practice nurses.
Greaves CJ; Brown P; Terry RT; Eiser C; Lings P; Stead JW
J Adv Nurs; 2003 Jun; 42(5):487-96. PubMed ID: 12752869
[TBL] [Abstract][Full Text] [Related]
23. Development of a decision aid to support colorectal cancer screening: perspectives of Asians in an endemic urban community-a qualitative research study.
Yuen SWJ; Tay TY; Gao N; Tho NQ; Tan NC
BMC Med Inform Decis Mak; 2021 Mar; 21(1):86. PubMed ID: 33676504
[TBL] [Abstract][Full Text] [Related]
24. Barriers to initiating insulin therapy in patients with type 2 diabetes mellitus in public-sector primary health care centres in Cape Town.
Haque M; Emerson SH; Dennison CR; Navsa M; Levitt NS
S Afr Med J; 2005 Oct; 95(10):798-802. PubMed ID: 16341336
[TBL] [Abstract][Full Text] [Related]
25. Adherence to premixed insulin in a prefilled pen compared with a vial/syringe in people with diabetes in Singapore.
Cheen HH; Lim SH; Huang MC; Bee YM; Wee HL
Clin Ther; 2014 Jul; 36(7):1043-53. PubMed ID: 24913030
[TBL] [Abstract][Full Text] [Related]
26. Insulin in general practice - barriers and enablers for timely initiation.
Furler J; Spitzer O; Young D; Best J
Aust Fam Physician; 2011 Aug; 40(8):617-21. PubMed ID: 21814661
[TBL] [Abstract][Full Text] [Related]
27. Beyond pros and cons - developing a patient decision aid to cultivate dialog to build relationships: insights from a qualitative study and decision aid development.
Yu CH; Ke C; Jovicic A; Hall S; Straus SE;
BMC Med Inform Decis Mak; 2019 Sep; 19(1):186. PubMed ID: 31533828
[TBL] [Abstract][Full Text] [Related]
28. [Why don't doctors use early insulinization therapy in patients with diabetes mellitus type 2?: A qualitative approach in a Mexican city].
Lagunes-Córdoba R; Galindo-Guevara I; Reyes AC; Romero-Aparicio C; Rosas-Santiago FJ
Salud Colect; 2017; 13(4):693-712. PubMed ID: 29340447
[TBL] [Abstract][Full Text] [Related]
29. Barriers to initiating insulin in type 2 diabetes patients: development of a new patient education tool to address myths, misconceptions and clinical realities.
Brod M; Alolga SL; Meneghini L
Patient; 2014; 7(4):437-50. PubMed ID: 24958464
[TBL] [Abstract][Full Text] [Related]
30. Moving towards culturally competent health systems for migrants? Applying systems thinking in a qualitative study in Malaysia and Thailand.
Pocock NS; Chan Z; Loganathan T; Suphanchaimat R; Kosiyaporn H; Allotey P; Chan WK; Tan D
PLoS One; 2020; 15(4):e0231154. PubMed ID: 32251431
[TBL] [Abstract][Full Text] [Related]
31. The introduction of insulin in type 2 diabetes mellitus.
Wong J; Tabet E
Aust Fam Physician; 2015 May; 44(5):278-83. PubMed ID: 26042399
[TBL] [Abstract][Full Text] [Related]
32. A 'combined framework' approach to developing a patient decision aid: the PANDAs model.
Ng CJ; Mathers N; Bradley A; Colwell B
BMC Health Serv Res; 2014 Oct; 14():503. PubMed ID: 25341370
[TBL] [Abstract][Full Text] [Related]
33. Current perspectives on psychological insulin resistance: primary care provider and patient views.
Krall J; Gabbay R; Zickmund S; Hamm ME; Williams KR; Siminerio L
Diabetes Technol Ther; 2015 Apr; 17(4):268-74. PubMed ID: 25551737
[TBL] [Abstract][Full Text] [Related]
34. Development of a hidradenitis suppurativa patient decision aid.
McBride O; McLean D; Samardzic T; Yannuzzi C; Guilbault S; Sayed C; Resnik B; Sisic M; Dellavalle RP; Tan J
Dermatol Online J; 2020 Nov; 26(11):. PubMed ID: 33342169
[TBL] [Abstract][Full Text] [Related]
35. Modified Delphi survey for the evidence summarisation of patient decision aids: Study protocol.
Durand MA; Dannenberg MD; Saunders CH; Giguere AMC; Alper BS; Hoffmann T; Perestelo-Pérez L; Campbell ST; Elwyn G
BMJ Open; 2019 Mar; 9(3):e026701. PubMed ID: 30904876
[TBL] [Abstract][Full Text] [Related]
36. Intensification to injectable therapy in type 2 diabetes: mixed methods study (protocol).
de Lusignan S; Hinton W; Konstantara E; Munro N; Whyte M; Mount J; Feher M
BMC Health Serv Res; 2019 May; 19(1):284. PubMed ID: 31053136
[TBL] [Abstract][Full Text] [Related]
37. Establishing the Cultural Equivalence of the Young Children's Participation and Environment Measure (YC-PEM) for Use in Singapore.
Lim CY; Law M; Khetani M; Pollock N; Rosenbaum P
Phys Occup Ther Pediatr; 2016 Nov; 36(4):422-39. PubMed ID: 26642891
[TBL] [Abstract][Full Text] [Related]
38. Diabetes Care in Malaysia: Problems, New Models, and Solutions.
Hussein Z; Taher SW; Gilcharan Singh HK; Chee Siew Swee W
Ann Glob Health; 2015; 81(6):851-62. PubMed ID: 27108152
[TBL] [Abstract][Full Text] [Related]
39. Danish Physicians' Views on the Appropriateness of the Involvement of Patients with Type 2 Diabetes in Regulatory Decision Making: A Qualitative Study.
Sachs ML; Colding-Jørgensen M; Helboe P; Sporrong SK; Frøkjaer S; Jelic K; Kaae S
Pharmaceut Med; 2019 Apr; 33(2):99-107. PubMed ID: 31933255
[TBL] [Abstract][Full Text] [Related]
40. NIDDM patients' fears and hopes about insulin therapy. The basis of patient reluctance.
Hunt LM; Valenzuela MA; Pugh JA
Diabetes Care; 1997 Mar; 20(3):292-8. PubMed ID: 9051375
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
